nach oben

CNS Drugs

Erschienen in:

01.08.2010 | Review Article

The Relationship between Benzodiazepine Use and Traffic Accidents

A Systematic Literature Review

verfasst von: Dr Beitske E. Smink, Antoine C. G. Egberts, Klaas J. Lusthof, Donald R. A. Uges, Johan J. de Gier

Erschienen in: CNS Drugs | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

In many countries, benzodiazepines are the most commonly used and misused psychoactive medicinal drugs. Results of epidemiological studies investigating the association between benzodiazepine use and traffic accidents seem to be inconclusive or inconsistent at first sight. However, the outcome of epidemiological studies may be influenced by several methodological factors like study design, study population, exposure measurement, outcome definitions and possible confounders.

Our objective was to conduct a systematic literature review of epidemiological studies that investigated the association between benzodiazepine use and traffic accidents, including related outcomes like culpability and injury or accident severity. We searched EMBASE, PubMed and Forensic Science Abstracts 3/0 (FORS®) for references included in these databases at 1 June 2009 using the term ‘benzodiazepines’ in combination with ‘driving performance’ or ‘accident risk’ or ‘traffic accident’. For inclusion in this review, the study design had to be comparative, include road users involved in accidents and provide specific data about benzodiazepines. Sixty-six studies were included in the review. The study populations varied from the general (driving) population, accident-involved road users with or without injury and persons admitted to a hospital to fatally injured accident-involved drivers. Exposure assessment was performed by using toxicological results, prescription data or questionnaires.The divergent study populations and comparison groups and the variety of methods used to express the outcome of interest hampered comparison between results.

Evidence is growing that exposure to benzodiazepines is related to increased accident risk. The literature indicates that the greatest accident risk is associated with the use of long half-life benzodiazepines, increasing dosage and the first few weeks of use of benzodiazepines. Clear evidence of increased culpability associated with benzodiazepine use is scarce. More research has to be done to elucidate the relationship between benzodiazepine use and injury severity.

Nur mit Berechtigung zugänglich

Walsh JM, De Gier JJ, Christophersen AS, et al. Drugs and driving. Traffic Inj Prev 2004; 5: 241–53PubMedCrossRef

Murray N. Metaminodiazepoxyde. JAMA 1960; 173: 1760–1CrossRef

Friedel B, Staak M. Benzodiazepines and driving. Rev Contemp Pharmacother 1992: V3-474

Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18: 297–328PubMedCrossRef

Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004; 8: 309–25PubMedCrossRef

De Gier JJ. Problems raised by the use/abuse of psychoactive drugs by drivers: report on the situation in 24 European countries. Proceedings of Road Traffic and Psychoactive Substances Seminar organised by the Pompidou Group; 2003 Jun 18–20; Strasbourg

Foundation for Pharmaceutical Statistics. Facts and figures 2006 [online]. Available from URL: http://www.sfk.nl/algemeen/english.html [Accessed 2010 Apr 29]

Jones AW. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev 2005; 6: 317–22PubMedCrossRef

Mykkanen S, Lillsunde P. The handling and statistics of suspected drugs and driving cases in Finland. Proceedings of the conference of the International Association of Forensic Toxicologists; 2006 Aug 27–Sept 1; Ljubljana

10.

Drummer OH, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 2003; 34: 154–62CrossRef

11.

Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and/or benzodiazepine use in injured road users. Hum Psychopharmacol 2003; 18: 361–7PubMedCrossRef

12.

Longo MC, Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part I. The prevalence of drug use in drivers, and characteristics of the drug-positive group. Accid Anal Prev 2000; 32: 613–22

13.

Meulemans A, Hooft P, Van Camp L, et al. Belgian Toxicology and Trauma Study (BTTS): a study on alcohol, medication and illicit drugs in drivers/victims of road traffic accidents. Report 1998; NK-101

14.

Mura P, Kintz P, Ludes B, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 2003; 133: 79–85PubMedCrossRef

15.

Smink BE, Ruiter B, Lusthof KJ, et al. Driving under the influence of alcohol and/or drugs in the Netherlands 1995–1998 in view of the German and Belgian legislation. Forensic Sci Int 2001; 120: 195–203PubMedCrossRef

16.

Rapoport MJ, Banina MC. Impact of psychotropic medications on simulated driving: a critical review. CNS Drugs 2007; 21: 503–19PubMedCrossRef

17.

Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf 2001; 10: 389–92PubMedCrossRef

18.

Strom BL. Methodologic challenges to studying patient safety and comparative effectiveness. Med Care 2007; 45(10 Suppl. 2): S13–5PubMedCrossRef

19.

Embase Biomedical Answers [online]. Available from URL: http://www.embase.com [Accessed 2009 Jun 1]

20.

National Centre for Biotechnology Information [online]. Available from URL: http://www.ncbi.nlm.nih.gov [Accessed 2009 Jun 1]

21.

Forensic Science Service [online]. Available from URL: http://www.forensic.gov.uk [Accessed 2009 Jun 1]

22.

Bo O, Haffner JWF, Langart O, et al. Ethanol and diazepam as causative in road traffic accidents. Proceedings of the 6th International Conference on Alcohol, Drugs and Traffic Safety; 1975 Sep 8–13; Toronto (ON), 439-48

23.

Bouchard J, Brault M. Link between driving records and the presence of drugs and/or alcohol in fatally injured drivers. Proceeding of the 17th International Conference on Alcohol, Drugs and Traffic Safety; 2004 Aug 8–13; Glasgow

24.

Christensen LQ, Nielsen LM, Nielsen SL. Traffic accidents and drivers suspected for drug influence. Forensic Sci Int 1990; 45: 273–80PubMedCrossRef

25.

Christophersen AS, Beylich KM, Bjorneboe A, et al. Prevalence of alcohol and drugs in blood samples from Norwegian drivers in road traffic accidents. Proceedings of the 13th International Conference on Alcohol, Drugs and Traffic Safety; 1995 Aug 13–18; Adelaide (SA), 768-72

26.

Cimbura G, Lucas DM, Bennett RC, et al. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. J Forensic Sci 1982; 27: 855–67PubMed

27.

Dussault S, Brault M, Bouchard J, et al. The contribution of alcohol and other drugs among fatally injured drivers in Québec: some preliminary results. Proceeding of the 16th International Conference on Alcohol Drugs and Traffic Safety; 2002; Aug 4–9; Québec (QC), 423-30

28.

Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007; 17: 597–602PubMedCrossRef

29.

French DD, Chirikos TN, Spehar A, et al. Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population. Drug Saf 2005; 28: 1141–50PubMedCrossRef

30.

Gibson JE, Hubbard RB, Smith CJP, et al. Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol 2009; 169: 761–8PubMedCrossRef

31.

Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818–22PubMedCrossRef

32.

Hebert C, Delaney JA, Hemmelgarn B, et al. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf 2007; 16: 845–9PubMedCrossRef

33.

Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27–31PubMedCrossRef

34.

Honkanen R, Ertama L, Linnoila M, et al. Role of drugs in traffic accidents. Br Med J 1980; 281: 1309–12PubMedCrossRef

35.

Jacobson B, Ysander L, Ojerskog B. Alcohol and drugs in road traffic accident victims. J Traffic Med 1983; 11: 28–33

36.

Jick H, Hunter JR, Dinan BJ, et al. Sedating drugs and automobile accidents leading to hospitalization. Am J Public Health 1981; 71: 1399–400PubMedCrossRef

37.

Leveille SG, Buchner DM, Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5: 591–8PubMedCrossRef

38.

MacDonald T. The impact of psychotropic medication on daily activities: psychotropic drugs and road traffic accidents: the MEMO Study. Prim Care Psychiatry 1999; 5: S13–6

39.

MacPherson RD, Perl J, Starmer GA. Self-reported drug usage and crash-incidence in breathalyzed drivers. Accid Anal Prev 1984; 16: 139–48CrossRef

40.

McGwin G, Sims RV, Pulley L, et al. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol 2000; 152: 424–31PubMedCrossRef

41.

Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004; 36: 631–6PubMedCrossRef

42.

Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5: 239–44PubMedCrossRef

43.

Neutel CI, Downey W, Senft D. Medical events after a prescription for a benzodiazepine. Pharmacoepidemiol Drug Saf 1995; 4: 63–73CrossRef

44.

Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol 1998; 13: S115-23

45.

Oster G, Russell MW, Huse DM, et al. Accident- and injury-related health-care utilization among benzodiazepine users and nonusers. J Clin Psychiatry 1987; 48: 17–21PubMed

46.

Oster G, Huse DM, Adams SF, et al. Benzodiazepine tranquilizers and the risk of accidental injury. Am J Public Health 1990; 80: 1467–70PubMedCrossRef

47.

Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873–83PubMedCrossRef

48.

Rapoport MJ, Herrmann N, Molnar F, et al. Psychotropic medications and motor vehicle collisions in patients with dementia. J Am Geriatr Soc 2008; 56: 1968–70PubMedCrossRef

49.

Skegg DC, Richards SM, Doll R. Minor tranquillisers and road accidents. Br Med J 1979; 1: 917–9PubMedCrossRef

50.

Tamblyn R, Abrahamowicz M, du Berger R, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53: 233–41PubMedCrossRef

51.

Wadsworth EJ, Moss SC, Simpson SA, et al. Preliminary investigation of the association between psychotropic medication use and accidents, minor injuries and cognitive failures. Hum Psychopharmacol 2003; 18: 535–40PubMedCrossRef

52.

Wadsworth EJK, Moss SC, Simpson SA, et al. Psychotropic medication use and accidents, injuries and cognitive failures. Hum Psychopharmacol 2005; 20: 391–400PubMedCrossRef

53.

‘Benzodiazepine/Driving’ Collaborative Group. Are benzodiazepines a risk factor for road accidents? Drug Alcohol Depend 1993; 33: 19–22CrossRef

54.

Currie D, Hashemi K, Fothergill J, et al. The use of anti-depressants and benzodiazepines in the perpetrators and victims of accidents. Occup Med 1995; 45: 323–5CrossRef

55.

Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004; 36: 239–48PubMedCrossRef

56.

Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331–6PubMedCrossRef

57.

Dubois S, Bédard M, Weaver B. The impact of benzo-diazepines on safe driving. Traffic Inj Prev 2008; 9: 404–13PubMedCrossRef

58.

Garriott JC, DiMaio VJ, Zumwalt RE, et al. Incidence of drugs and alcohol in fatally injured motor vehicle drivers. J Forensic Sci 1977; 22: 383–9PubMed

59.

Longo MC, Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part II. The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000; 32: 623–32

60.

Terhune KW. The role of alcohol, marijuana and other drugs in the accidents of injured drivers: report no. DOT HS 501 179. Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration, 1982

61.

Terhune KW. The incidence and role of drugs in fatally injured drivers: report no. DOT HS 808 065. Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration, 1992

62.

Williams AF, Peat MA, Crouch DJ, et al. Drugs in fatally injured young male drivers. Public Health Rep 1985; 100: 19–25PubMed

63.

Adams JE, Davis GG, Alexander CB, et al. Pelvic trauma in rapidly fatal motor vehicle accidents. J Orthop Trauma 2003; 17: 406–10PubMedCrossRef

64.

Ahlm K, Björnstig U, Oström M. Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden. Accid Anal Prev 2009; 41: 129–36PubMedCrossRef

65.

Barnas C, Miller CH, Sperner G, et al. The effects of alcohol and benzodiazepines on the severity of ski accidents. Acta Psychiatr Scand 1992; 86: 296–300PubMedCrossRef

66.

Kirby JM, Maull KI, Fain W. Comparability of alcohol and drug use in injured drivers. South Med J 1992; 85: 800–2PubMedCrossRef

67.

Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and/or benzodiazepine use: different accidents —different impacts? Hum Psychopharmacol 2005; 20: 583–9PubMedCrossRef

68.

Levy RS, Hebert CK, Munn BG, et al. Drug and alcohol use in orthopedic trauma patients: a prospective study. J Orthop Trauma 1996; 10: 21–7PubMedCrossRef

69.

Rivara FP, Mueller BA, Fligner CL, et al. Drug use in trauma victims. J Trauma 1989; 29: 462–70PubMedCrossRef

70.

Sjogren H, Bjornstig U, Eriksson A, et al. Drug and alcohol use among injured motor vehicle drivers in Sweden: prevalence, driver, crash, and injury characteristics. Alcohol Clin Exp Res 1997; 21: 968–73PubMedCrossRef

71.

Smink BE, Movig KLL, Lusthof KJ, et al. The relation between the use of psychoactive substances and the severity of the injury in a group of crash-involved drivers admitted to a regional trauma center. Traffic Inj Prev 2008; 9: 105–8PubMedCrossRef

72.

Stoduto G, Vingilis E, Kapur BM, et al. Alcohol and drug use among motor vehicle collision victims admitted to a regional trauma unit: demographic, injury, and crash characteristics. Accid Anal Prev 1993; 25: 411–20PubMedCrossRef

73.

Bramness JG, Skurtveit S, Morland J. Clinical impairment of benzodiazepines: relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend 2002; 68: 131–41PubMedCrossRef

74.

Bramness JG, Skurtveit S, Morland J. Testing for benzodiazepine inebriation: relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur J Clin Pharmacol 2003; 59: 593–601PubMedCrossRef

75.

Kuitunen T, Aranko K, Nuotto E, et al. The relationship between blood benzodiazepine concentrations and the clinical test for drunkenness in drivers suspected of driving under the influence of drugs. Alcohol Drug Driving 1994; V10-146

76.

Kuitunen T, Meririnne E, Seppala T. Correlation between blood diazepam concentrations and performance on the clinical test for drunkenness in acute and chronic diazepam users. J Traffic Med 1994; 22: 105–11

77.

Missen AW, Cleary W, Eng L, et al. Diazepam, alcohol and drivers. N Z Med J 1978; 87: 275–7PubMed

78.

Smink BE, Lusthof KJ, de Gier JJ, et al. The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers. J Forensic Leg Med 2008; 15: 483–8PubMedCrossRef

79.

Vinkers DJ, Gussekloo J, Van Der Mast RC, et al. Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003; 290: 2942–3PubMedCrossRef

80.

IMMORTALR4. 2. The prevalence of drug driving and relative risk estimations: a study conducted in The Netherlands, Norway and the United Kingdom, 2005 Jun 22 [online]. Available from URL: http://www.immortal.or.at/deliverables.php#top [Accessed 2010 Apr 15]

81.

Binnie GAC. Psychotropic drugs and accidents in a general practice. Br Med J 1983; 287: 1349CrossRef

82.

Smink BE, Ruiter B, Lusthof KJ, et al. Drug use and the severity of a traffic accident. Accid Anal Prev 2005; 37: 427–33PubMedCrossRef

83.

Longo MC, Lokan RJ, White JM. The relationship between blood benzodiazepine concentration and vehicle crash culpability. J Traffic Med 2001; 29: 36–43

84.

Verster JC, Volkerts ER, Olivier B, et al. Zolpidem and traffic safety: the importance of treatment compliance. Curr Drug Saf 2007; 2: 220–6PubMedCrossRef

85.

Gustavsen I, Al-Sammurraie M, Morland J, et al. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev 2009; 41: 462–6PubMedCrossRef

86.

Robertson MD, Drummer OH. Responsibility analysis: a methodology to study the effects of drugs in driving. Accid Anal Prev 1994; 26: 243–7PubMedCrossRef

87.

Van Laar MW, Volkerts ER. Driving and benzodiazepine use: evidence that they do not mix. CNS Drugs 1998; 10: 383–96CrossRef

88.

O’Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005; 66 Suppl. 2: 28–33

89.

Riss J, Cloyd J, Gates J, et al. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008; 118: 69–86PubMedCrossRef

90.

Rapoport MJ, Lanctot KL, Streiner DL, et al. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 2009; 70: 663–73PubMedCrossRef

Titel: The Relationship between Benzodiazepine Use and Traffic Accidents
A Systematic Literature Review
verfasst von: Dr Beitske E. Smink
Antoine C. G. Egberts
Klaas J. Lusthof
Donald R. A. Uges
Johan J. de Gier
Publikationsdatum: 01.08.2010
Verlag: Springer International Publishing
Erschienen in: CNS Drugs / Ausgabe 8/2010
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI: https://doi.org/10.2165/11533170-000000000-00000

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2010

Awakenings and Awareness Recovery in Disorders of Consciousness

Nervous System Effects of Antituberculosis Therapy

Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

Low-Dose Doxepin